Pressure BioSciences, Inc. President and CEO, Richard T. Schumacher, Discusses Recent Company Achievements with Everett Jolly on Uptick Newswire’s “Stock Day” Podcast
August 09, 2018 08:30 ET | Pressure BioSciences, Inc.
PHOENIX, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Uptick Newswire today announced the release of an interview with Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB:PBIO) (the...
Everett Jolly, Host of “Stock Day” Welcomes Richard T. Schumacher of Pressure BioSciences Back on the Show to Discuss Significant Debt to Equity Conversions and other Recent Accomplishments
June 18, 2018 08:00 ET | Pressure BioSciences, Inc.
PHOENIX, June 18, 2018 (GLOBE NEWSWIRE) -- Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB:PBIO) (“PBI” and “the Company”) was recently interviewed on Uptick Newswire’s...
Richard T. Schumacher, CEO of Pressure BioSciences, Joins Everett Jolly on Uptick Newswire’s “Stock Day” Podcast to Discuss Important New Contract from International Bio-Therapeutic Company and Other Recent Achievements
May 10, 2018 07:30 ET | Pressure BioSciences, Inc.
PHOENIX, May 10, 2018 (GLOBE NEWSWIRE) -- Richard T. Schumacher, President and CEO of Pressure Biosciences, Inc. (OTCQB:PBIO) (“PBI” and “the company”), joined Everett Jolly on the “Stock Day”...
Richard T. Schumacher, CEO of Pressure BioSciences, Inc., Discusses Strong Finish to 2017 and Operational Developments for 2018 on Uptick Newswire’s “Stock Day” Podcast with Everett Jolly
April 10, 2018 11:38 ET | Pressure BioSciences, Inc.
PHOENIX, April 10, 2018 (GLOBE NEWSWIRE) -- Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Company"), a leader in the development and sale of...
Richard T. Schumacher, CEO of Pressure BioSciences, Inc., Returns to Uptick Newswire's "Stock Day" Podcast with Everett Jolly to Review Significant Achievements in 2017 and Discuss Exciting Developments Expected in 2018
March 13, 2018 08:08 ET | Pressure BioSciences, Inc.
Phoenix, March 13, 2018 (GLOBE NEWSWIRE) -- Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of...
Pressure BioSciences, Inc. CEO, Ric Schumacher, Rejoins “Stock Day”, Very Optimistic About His Company’s Growth and Success in 2018 and Beyond
January 29, 2018 11:09 ET | Pressure BioSciences, Inc.
PHOENIX, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Mr. Richard T. Schumacher, CEO and President of Pressure BioSciences, Inc. (OTCQB:PBIO) (the “Company”) returns to the “Stock Day” podcast for the first...
CEO Richard T. Schumacher Discusses Pressure BioScience’s New Sales Team and Novel Products that are Fueling its Progressive Upturn
October 10, 2017 09:30 ET | Pressure BioSciences, Inc.
Phoenix, AZ.,, Oct. 10, 2017 (GLOBE NEWSWIRE) -- Richard T. Schumacher, CEO of Pressure BioSciences, Inc. (OTCQB: PBIO) (the “Company”), was recently interviewed on the Uptick Network Stock Day...
PBI vertical.jpg
Ironridge BioPharma to Invest $500,000 in Pressure BioSciences
April 09, 2012 08:15 ET | Pressure BioSciences, Inc.
SOUTH EASTON, Mass., April 9, 2012 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company") today announced that it has entered into a definitive agreement with Ironridge...
PBI vertical.jpg
Pressure BioSciences Common Stock to Begin Trading Today on the OTCQB(TM) Tier of the OTC Marketplace
April 05, 2012 09:59 ET | Pressure BioSciences, Inc.
SOUTH EASTON, Mass., April 5, 2012 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that its common stock will begin trading on the OTCQB tier of...
PBI vertical.jpg
Pressure BioSciences and Sage-N Research to Collaborate on Improving the Extraction and Analysis of Integral Cell Membrane Proteins That May be Associated With Cancer, Stroke, and Other Diseases and Disorders
March 19, 2012 10:35 ET | Pressure BioSciences, Inc.
SOUTH EASTON, Mass. and MILPITAS, Calif., March 19, 2012 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (Nasdaq:PBIO) ("PBI" and the "Company"), a leading sample preparation tools company for the...